Given the capacity for BDNF to regulate attention and impulsivity, the promising roles of pharmacological and exercise interventions increasing BDNF expression are more effective behavioral variants largely emerging and existing from rodent models of ADHD and therefore an effective therapeutically viable target [70,71]. The gene discussed is BDNF; the disease is attention deficit-hyperactivity disorder.